Case Report: PTEN Mutation Induced by anti-PD-1 Therapy in Stage IV Lung Adenocarcinoma

Lung cancer is the most common solid tumor in the worldwide. Targeted therapy and immunotherapy are important treatment options in advanced non-small cell lung cancer (NSCLC). The association of PTEN mutation and tumor immunotherapy is less established for patients with NSCLC. We present the case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Junjie, Zhou, Kai, Lv, Dongxiao, Wu, Changshun, Feng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168362/
https://www.ncbi.nlm.nih.gov/pubmed/35677433
http://dx.doi.org/10.3389/fphar.2022.714408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168362/
https://www.ncbi.nlm.nih.gov/pubmed/35677433
http://dx.doi.org/10.3389/fphar.2022.714408

Ejemplares similares